Gall stone ileus is complication of cholithiasis. It is rare and seen in aged patients diagnosed as
cholelithiasis with co morbidities. High index of suspicion is necessary for arriving at a clinical diagnosis.
Contrast enhanced computed tomography is diagnostic. Enterolithotomy followed by closure of the fistula
with cholecystectomy as a two staged procedure is the safest approach for managing gall stone ileus.
Gallstones:
Most common biliary pathology
Asymptomatic in majority of cases (>80%)
Approx. 1–2% of asymptomatic patients develop symptoms requiring cholecystectomy per year.
etiology ,classifications of gall stones & causes,risk factors,presentations, clinical examinations ,investigations including radiological (role of ERCP and MRCP ) and serological ,treatment including surgical and non surgical ,post cholecystectomy syndrome and its management ,Iindicatrions for cholecystectomy and cholecystotomy & when to perform ,complications of gall stones ,preventions of gall stone disease
Choledocholithiasis is one of the main causes for Obstructive Jaundice.In this ppt presentation, I have discussed the etiology, clinical features, complications, investigations and management of Choledocholithiasis. I have also included a mindmap and 2 algorithms for Choledocholithiasis. I hope you will find it very useful and interesting.
Gallstones are small, pebble-like substances that develop in the
gallbladder. The gallbladder is a small, pear-shaped sac located below
your liver in the right upper abdomen. Gallstones form when liquid
stored in the gallbladder hardens into pieces of stone-like material.
The liquid—called bile—helps the body digest fats. Bile is made in the
liver, then stored in the gallbladder until the body needs it. The
gallbladder contracts and pushes the bile into a tube—called the common
bile duct—that carries it to the small intestine, where it helps with
digestion.
Bile contains water, cholesterol, fats, bile salts, proteins, and
bilirubin—a waste product.
Bile salts break up fat, and bilirubin gives bile and stool a
yellowish-brown color. If the liquid bile contains too much cholesterol,
bile salts, or bilirubin, it can harden into gallstones.
The two types of gallstones are cholesterol stones and pigment
stones. Cholesterol stones are usually yellow-green and are made
primarily of hardened cholesterol. They account for about 80 percent of
gallstones. Pigment stones are small, dark stones made of bilirubin.
Gallstones can be as small as a grain of sand or as large as a golf
ball. The gallbladder can develop just one large stone, hundreds of tiny
stones, or a combination of the two.
Gall stone ileus is complication of cholithiasis. It is rare and seen in aged patients diagnosed as
cholelithiasis with co morbidities. High index of suspicion is necessary for arriving at a clinical diagnosis.
Contrast enhanced computed tomography is diagnostic. Enterolithotomy followed by closure of the fistula
with cholecystectomy as a two staged procedure is the safest approach for managing gall stone ileus.
Gallstones:
Most common biliary pathology
Asymptomatic in majority of cases (>80%)
Approx. 1–2% of asymptomatic patients develop symptoms requiring cholecystectomy per year.
etiology ,classifications of gall stones & causes,risk factors,presentations, clinical examinations ,investigations including radiological (role of ERCP and MRCP ) and serological ,treatment including surgical and non surgical ,post cholecystectomy syndrome and its management ,Iindicatrions for cholecystectomy and cholecystotomy & when to perform ,complications of gall stones ,preventions of gall stone disease
Choledocholithiasis is one of the main causes for Obstructive Jaundice.In this ppt presentation, I have discussed the etiology, clinical features, complications, investigations and management of Choledocholithiasis. I have also included a mindmap and 2 algorithms for Choledocholithiasis. I hope you will find it very useful and interesting.
Gallstones are small, pebble-like substances that develop in the
gallbladder. The gallbladder is a small, pear-shaped sac located below
your liver in the right upper abdomen. Gallstones form when liquid
stored in the gallbladder hardens into pieces of stone-like material.
The liquid—called bile—helps the body digest fats. Bile is made in the
liver, then stored in the gallbladder until the body needs it. The
gallbladder contracts and pushes the bile into a tube—called the common
bile duct—that carries it to the small intestine, where it helps with
digestion.
Bile contains water, cholesterol, fats, bile salts, proteins, and
bilirubin—a waste product.
Bile salts break up fat, and bilirubin gives bile and stool a
yellowish-brown color. If the liquid bile contains too much cholesterol,
bile salts, or bilirubin, it can harden into gallstones.
The two types of gallstones are cholesterol stones and pigment
stones. Cholesterol stones are usually yellow-green and are made
primarily of hardened cholesterol. They account for about 80 percent of
gallstones. Pigment stones are small, dark stones made of bilirubin.
Gallstones can be as small as a grain of sand or as large as a golf
ball. The gallbladder can develop just one large stone, hundreds of tiny
stones, or a combination of the two.
Nuclear medicine in biliary tract disordersRamin Sadeghi
In this presentation, application of nuclear medicine in biliary tract disorders is explained including cholecystitis, sphicter of Oddi dysfunction, neonatal cholestasis, biliary leak, etc.
This is an overview of gallbladder stone diseases and infection of the gallbladder. I started with the surgical anatomy and physiology of gallbladder and bile secretion. furthermore, I went ahead to discuss the natural history of gallstones. then, the pathology and pathogenesis of gallstones and gallbladder infection (cholecystitis). Various investigations for Cholelithiasis and cholecystitis was discussed and the concluding part talked about various treatment modality. Finally, I went ahead to show the techniques of laparoscopic cholecystectomy.
A presentation by Dr Dave Collins of SASH Vets Sydney
on Canine Biliary Disease - Gallbladder mucocoeles, Cholangitis and Extrahepatic bile duct obstruction.
4 Things You Should Know About Gallstones- Dr. Samrat JankarDr. Samrat Jankar
Discover the essential insights on gallstones: their causes, symptoms, treatment options, and prevention strategies. Get empowered with crucial knowledge about managing gallstone issues effectively.
Ulcerative colitis is a diffuse non- specific inflammatory disease of the large intestine of unknown cause, primarily affecting the mucosa, characterized by erosions and/or ulcerations. The disease is characterized by repeated cycles of relapses and remissions, occasionally accompanied by extra-intestinal manifestations.
A variety of immunologic changes have been documented in UC. T cells accumulate in the lamina propria of the diseased colonic segment. these T cells are cytotoxic to colonic epithelium. This change is accompanied by an increase in the population of B cells and plasma cells, with increased production of immunoglobulin G (IgG) and immunoglobulin E (IgE).
Ant colonic antibodies have been detected in patients with UC. A small proportion of patients with ulcerative colitis have smooth muscle and ant cytoskeletal antibodies.
Microscopically, acute and chronic inflammatory infiltrate of the lamina propria, crypt branching, and villous atrophy are present in ulcerative colitis. Microscopic changes also include inflammation of the crypts of Lieberkühn and abscesses. These findings are accompanied by a discharge of mucus from the goblet cells, the number of which is reduced as the disease progresses. The ulcerated areas are soon covered by granulation tissue. Excessive fibrosis is not a feature of the disease. The undermining of mucosa and an excess of granulation tissue lead to the formation of pseudo polyps.
Similar to Gallstones Causes and Management -Dr Kedar Patil Pune (20)
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Gallstones Causes and Management -Dr Kedar Patil Pune
1. Dr Kedar Patil
D.N.B-Gen. Surgery, F.N.B-Minimal Access Surgery,
Fellow Bariatric and Metabolic Surgery -Taiwan,
Fellow G.I Oncosurgery, Tata Memorial Hospital, Mumbai
Bariatric and Metabolic, G.I Onco surgeon and Advanced Laparoscopic Surgeon
Poona Hospital ,Bharati Hospital Pune and Sangli
8888655455,presizeclinic@gmail.com,www.lifedocsindia.com
2. Bile Contents
Bile Pigments
Bile Salts –Cholic and Chenodexoycholic acid
Phospholipids and Cholesterol –Serves absorption of
dietary lipids and avoids toxic effect of bile on
hepatocytes
Bilirubin –End products of globin and myoglobin
excreted with bile salts
presizeclinic@gmail.com. 8888655455,www.lifedocsindia.com
3. Physiology of bile
Bile fills in Gall bladder
retrograde method due
to Sphicter Of Oddi
CCK and Vagi influence
on Sphicter Of Oddi
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
5. Pathogenesis of Gallstone
formation
Supersaturation of Secreted Bile
Concentration of bile in GB
Crystal nucleation
Gallbladder dysmotility
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
6. Types Of Stones
Pigment Stones – Black or brown
Black-Hemoglobinopathies or cirrhosis,usually in bile
duct and GB
Brown –Bacterial infections and motility disorders
,Found anywhere
Pure Chlolesterol stones (10%)-Yellow
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
7. Natural history of Stones
Asymptomatic –When free floating in GB
Symptomatic –When obstructs a Cystic Duct or passes
in CBD
20-30% Asymptomatic stone patient develop
symptoms
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
8. Factors affecting Gallstone
formation
Gall stone Promoting Gallstone Preventing
Higher Cholesterol and Lipid
Increased Hemoglobin
processing –
hemoglobinopathies
Fasting ,Burns TPN
Glycoproteins and Ig-
Pronucleating agents
Gall bladder dysmotility
Bile salts
CCK
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
9. Clinical features
Biliary Colic –Misnomer ,since it’s a constant pain in
right upper quadrant or epigastrium
Due to incomplete emptying of G.B
Pain –associated with food in epigastrium
Fever –Systemic response to inflammation
Jaundice – 2.5 gm/dl Scleral Icterus ,5 gm/dl- Skin
manifestation
Pain ,Fever and jaundice –Charcots triad
Pain ,Fever,Jaundice,Hypotension and Altered
mentation –Reynolds Pentad (Indicates sepsis)
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
10. Clinical Features
Acute Cholecystitis –Pain >24 hours .May progress to
gangrene
‘Murphys sign’- Tenderness in right upper quadrant
Jaundice –Seen in cases of choledocholithiasis or
Mirrizzis Syndrome .
Most common presentation is ‘Dyspepsia’-belching or
bloating after food or discomfort
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
11. Investigations
LFTs – Raised Direct S.Bilirubin and Alkaline
Phosphatase indicate an Obstructive Pattern
S.Amylase and S.Lipase- Raised in Gallstone
pancreatitis
Ultrasound - Sensitive than CT for gallstones .
Gallstones,CBD Stones,CBD Diameter,Wall thickening
of G.B,Pericholecystic fluid etc can be known
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
13. Investigations
CT Abdomen –when malignancy is suspected or to
rule out CBD calculi
Evaluation of CBD Injury and collections
MRCP- Most sensitive for biliary pathologies
HIDA Scan – Biliary excretion and level of leak or
obstruction,useful in biliary dyskinesia
ERCP- Diagnostic-for strictures
Therapeutic ERCP for stones / malignant obstruction
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
14. MRCP for Biliary tract
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
15. Investigations
PTC-Percutanpercutaneous transhepatic
cholangiography (PTC) is an invasive procedure used
to evaluate the biliary tree. Useful for patients with
intrahepatic biliary disease or in whom ERCP is not
technically feasible, PTC can decompress biliary
obstruction, stent obstructions nonoperatively, and
provide anatomic information for biliary
reconstruction.
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
16. Other Modalities Of Investigation
Endoscopic Ultrasound (EUS )-Biliary strictures and
malignancy ,Sludge
Intraoperaative Cholangiogram –For
Choledocholithiasis ,Injury , Anatomy Unclear
PET Scan –Malignancy suspected
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
17. Management
Medical –Not much role except UDCA -300 mg twice
daily for 6 months ,review with USG.Only
recommended in high risk and asympromatic
individuals
Surgical –Laparoscopic Cholecystectomy is the Gold
standard
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
18. Laparoscopic Cholecystectomy
Who require it –Symptoms of Gallstones-Bloating
,Dyspepsia
High risk individuals even if asymptomatic –
Hemolytic anemia/Sickle cell anemia
Porcelian gall bladder
Large stones >2.5 cm
Few Bariatric Surgeries and transplant surgeries
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
19. Laparoscopic Cholecystectomy
One of the most common surgery done worldwide
Erich Muhe from Germany performed first
Laparoscopic Cholecystectomy in 1982
1-3% Complication rate in acute setting
Subtotal Cholecystectomy or Cholecystostomy
(Draining the Gall bladder ) alternatives in high risk
individuals
In Acute Cholecystitis – Operated within first 7 days or
delayed upto 6 weeks to prevent CBD Injury
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
20. Complications of Gallstones
Acute Cholecystitis and its sequale
Gangrene,Emphysematous
Gallstone Pancreatitis
Gallstone Ileus –Passing into small bowel through
duodenal fistula
Obstructive Jaundice
GB Malignancy –Porcelian GB and stones >3cms has
greater risk
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
21. Choledocholithiasis
Means –Stones in the CBD
Primary –Brown stones ; associated with infection
Secondary –Black –retained or migrated from GB
Can cause Pancreatitis as well
Specific Investigations-S.Biirubin ,S.Alkaline
Phosphate ,ERCP,MRCP
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
22. Choledocholithiasis
Treatment – ERCP /Lap
or Open CBD
Exploration with
Cholecystsectomy
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com
23. Thanks for your Patient listening !
www.presizeclinic@gmail.com
8888655455
presizeclinic@gmail.com.
8888655455,www.lifedocsindia.com